AUSA Admin
November 29, 2019
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) has appointed Squar Milner, LLP as its auditor. Squar Milner, LLP will replace MNP, LLP effective November 27, 2019.
November 18, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator is pleased to provide an update on the ShowGrow dispensary in San Diego, California.
November 14, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator, is pleased to announce its financial results for the fiscal year ended July 31, 2019 and is providing shareholders with an operational update.
October 29, 2019
Australis Capital Inc. (CSE: AUSA OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce the formation of Cocoon Technology LLC (“Cocoon”), a cloud-based, self-service fulfillment platform and wholly-owned subsidiary of AUSA.
October 21, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”) a multi-state operator is pleased to announce that Brent Reuter has been appointed to the Board of Directors as Australis Capital Inc.’s nominee on the Board of Directors and replaces Scott Dowty who has resigned from the Board or Directors.
October 17, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”) a multi-state operator, is pleased to update shareholders on the construction of its fully funded medical marijuana dispensary in West Memphis, Arkansas.
October 2, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”) a multi-state operator is pleased to announce the appointment of David Wenger to the Board of Directors.
October 1, 2019
Australis Capital Inc. (CSE: AUSA OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that AUSA has been granted a Special Use Permit by the city of North Las Vegas for the Tropical Parkway land acquired in the Green Therapeutics acquisition.
September 30, 2019
Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator, today announced that Michael Mills, President and Interim CEO, will present at the Canaccord Genuity U.S. Cannabis Symposium to be held at the Sheraton Centre Toronto Hotel in Toronto, Canada on Thursday, October 3, 2019 at 2:50 PM ET on Track 3.